---
title: "IM Cannabis (IMCC) stock listing, news and investor profile"
url: "https://aibio.space/companies/im-cannabis/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "IM Cannabis Corp. (NASDAQ: IMCC), United States. Listing facts, related biotech companies and news on aibio.space."
---

IMCC IM Cannabis Corp. NASDAQ · United States

# IM Cannabis (IMCC) news

IM Cannabis Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IMCC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest IM Cannabis news

We have not published a story on IM Cannabis yet. When there is news, it will appear here.

## IM Cannabis at a glance

- **Ticker**: IMCC

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Dec 31, 2025**: C$2.7 million

### Related companies

- [PROCEPT BioRobotics](https://aibio.space/companies/procept-biorobotics/) NASDAQ: PRCT
- [Synergy CHC](https://aibio.space/companies/synergy-chc/) OTC: SNYRQ
- [DENTSPLY SIRONA](https://aibio.space/companies/dentsply-sirona/) NASDAQ: XRAY
- [Yubo International Biotech](https://aibio.space/companies/yubo-international-biotech/) OTC: YBGJ
- [Research Alliance Corp III](https://aibio.space/companies/research-alliance-iii/) NASDAQ: RACC
- [WEED, INC.](https://aibio.space/companies/weed/) OTC: BUDZ
- [Global Innovative Platforms](https://aibio.space/companies/global-innovative-platforms/) OTC: GIPL
- [Vivos Therapeutics](https://aibio.space/companies/vivos-therapeutics/) NASDAQ: VVOS

### Also on NASDAQ

- [ORTHOPEDIATRICS CORP](https://aibio.space/companies/orthopediatrics/) KIDS
- [Oruka Therapeutics](https://aibio.space/companies/oruka-therapeutics/) ORKA
- [BioVie](https://aibio.space/companies/biovie/) BIVI
- [Nano-X Imaging](https://aibio.space/companies/nano-x-imaging/) NNOX
- [Cerenome](https://aibio.space/companies/cerenome/) CNSY
- [Neumora Therapeutics](https://aibio.space/companies/neumora-therapeutics/) NMRA

## IM Cannabis annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [C$54.7 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) | [C$54.0 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) |
| Net income (loss) | [-C$11.8 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) | [-C$11.8 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) |
| Cash from operations | [C$4.7 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) | [-C$1.1 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) |
| Cash and equivalents | [C$2.7 million](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) | [C$863,000](https://www.sec.gov/Archives/edgar/data/1792030/000117891326001877/) |

Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents C$2.7 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about IM Cannabis

What is the ticker symbol of IM Cannabis?

IM Cannabis Corp. trades under the ticker IMCC on NASDAQ.

Where is IM Cannabis listed?

IM Cannabis Corp. is listed on NASDAQ.

Which country or territory is IM Cannabis listed under?

Our directory records IM Cannabis Corp. under United States.

Does aibio.space cover IM Cannabis?

aibio.space lists IM Cannabis Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

## Investor discussion: IM Cannabis

Members talk about IM Cannabis (IMCC). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at IM Cannabis, newest first. Each line links the filing it comes from.

1. 2026-08-27 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1792030/000117891326004289/exhibit_99-1.htm)
2. 2026-08-18 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1792030/000117891326004186/exhibit_99-1.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IMCC on TradingView](https://www.tradingview.com/symbols/NASDAQ-IMCC/).

## Listing details

IM Cannabis Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IMCC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: IM Cannabis Corp.

- **Ticker**: IMCC

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/im-cannabis/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "IM Cannabis (IMCC) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/im-cannabis/
